Cumberland Pharmaceuticals (CPIX) Research & Development (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Research & Development across 17 years of filings, most recently posting $1.5 million for Q1 2026.

• Research & Development for Q1 2026 came in at $1.5 million, up 12.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.7 million (up 15.68% YoY), and the FY2025 annual result was $5.6 million, up 15.58% from the prior year.
• Research & Development came in at $1.5 million for Q1 2026 at Cumberland Pharmaceuticals, down from $1.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $1.9 million in Q3 2023 to a low of $1.1 million in Q2 2024.
• The 5-year median for Research & Development is $1.4 million (2022), against an average of $1.4 million.
• Across the five-year window, Research & Development surged 38.79% in 2022 and sank 37.21% in 2023, its largest moves.
• Cumberland Pharmaceuticals' Research & Development stood at $1.4 million in 2022, then decreased by 10.04% to $1.3 million in 2023, then advanced by 2.21% to $1.3 million in 2024, then grew by 19.88% to $1.5 million in 2025, then dropped by 5.89% to $1.5 million in 2026.
• The last three Research & Development figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.